Outcomes for patients with chronic lymphocytic leukemia (CLL) previously treated with both a covalent BTK and BCL2 inhibitor in the United States: A real-world database study

2022
Mato AR, Hess LM, Chen Y, Abada PB, Konig H, Pagel JM, Walgren RA
Read more